Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age2+
SponsorDong-A ST Co., Ltd.
About this trial
This study evaluates long-term safety and effectiveness of Growtropin®-II treatment in children with short stature.
Eligibility criteria
Qualifiers
Children with short stature by growth hormone deficiency(GHD) or idiopathic short stature (ISS) or turner's syndrome(TS) or small for gestational age(SGA)
Children who has official height record at least 6 months prior
Disqualifiers
Children with Epiphyseal closure
Trial design
Treatments tested in this trial
- Not listed
Trial groups
2,500 Participants
are grouped into 1 trial groupLocations
1Yonsei University Health System, Severance Hospital03722, SeoulSeodaemun-gu, South Korea
Sponsors and collaborators
Dong-A ST Co., Ltd.
Lead sponsor
Source ClinicalTrials.gov